Back
Osisko Gold Royalties Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
29
OR
Osisko Gold Royalties
Last Price:
15.36
Seasonality Move:
-7.55%
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
71.08
Seasonality Move:
3.75%
Sell
29
Osisko Gold Royalties (OR)
is a Sell
Is Osisko Gold Royalties a Buy, Sell or Hold?
- The current Osisko Gold Royalties [OR] share price is $15.37. The Score for OR is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- OR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $71.09. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OR Stock Price Chart
What is Osisko Gold Royalties's stock price today?
-
The Osisko Gold Royalties share price today is $15.37
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OR is experiencing slight selling pressure.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $71.09
The current trend is moderately bullish and ITCI is experiencing slight selling pressure.
OR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 35.31 | Sell |
Chaikin Money Flow: | -82388 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.52 | Buy |
Relative Strength Index (14 RSI): | 52.48 | Buy |
Chaikin Money Flow: | -481921 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
OR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.07 | Sell |
20-day SMA: | 16.44 | Sell |
50-day SMA: | 16.2 | Sell |
200-day SMA: | 14.52 | Buy |
8-day EMA: | 15.95 | Sell |
20-day EMA: | 16.24 | Sell |
50-day EMA: | 16.17 | Sell |
200-day EMA: | 15.12 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.91 | Sell |
20-day SMA: | 69.93 | Buy |
50-day SMA: | 69.79 | Buy |
200-day SMA: | 64.35 | Buy |
8-day EMA: | 72.51 | Sell |
20-day EMA: | 70.78 | Buy |
50-day EMA: | 69.5 | Buy |
200-day EMA: | 65.71 | Buy |
Osisko Gold Royalties Earnings Growth & OR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $0.03 per share, and an increase next year of $0.08 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.09 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.
Osisko Gold Royalties Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |